1-2 of 2
Mark R. Dowling
Close
Sort by
Journal Articles

ICANS prophylaxis: potentially transformative but elusive

Clinical Trials & Observations
Mark R. Dowling, Cameron J. Turtle
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6782–6784.
https://doi.org/10.1182/bloodadvances.2023011027
Published: 2023
Journal Articles

Germline heterozygous mutations in Nxf1 perturb RNA metabolism and trigger thrombocytopenia and lymphopenia in mice

Stéphane Chappaz, Charity W. Law, Mark R. Dowling, Kirstyn T. Carey, Rachael M. Lane, Linh H. Ngo, Vihandha O. Wickramasinghe, Gordon K. Smyth, Matthew E. Ritchie, Benjamin T. Kile
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1270–1283.
https://doi.org/10.1182/bloodadvances.2019001323
Published: 2020
Includes: Supplemental data